| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |